BRIEF published on 10/01/2024 at 13:41, 1 year 7 months ago Novacyt Provides Monthly Update on Liquidity Agreement and Total Voting Rights Shareholders Voting Rights Liquidity Agreement INVEST SECURITIES Novacyt
BRIEF published on 10/01/2024 at 13:41, 1 year 7 months ago Novacyt publie une mise à jour mensuelle sur l'accord de liquidité et le total des droits de vote Actionnaires Droit De Vote Novacyt Accord De Liquidité Investir Dans Des Titres
PRESS RELEASE published on 10/01/2024 at 13:39, 1 year 7 months ago Information mensuelle sur le contrat de liquidité et sur le nombre total de droits de vote Novacyt publie son bilan mensuel du contrat de liquidité et du nombre total de droits de vote. Consultez les détails de l'opération et les contacts clés de l'entreprise Contrat Droits De Vote Liquidité Actions Ordinaires Novacyt
PRESS RELEASE published on 10/01/2024 at 13:36, 1 year 7 months ago Liquidity Agreement Monthly Update and Total Voting Rights Novacyt provides a monthly update on its liquidity agreement with Invest Securities SA and discloses total voting rights. The agreement involves purchasing and selling ordinary shares under French law Liquidity Agreement Total Voting Rights French Law Novacyt Invest Securities SA
PRESS RELEASE published on 09/17/2024 at 10:28, 1 year 7 months ago Lancement du nouveau site web Novacyt annonce le lancement de son nouveau site web, offrant un large portefeuille de services de diagnostic moléculaire. Visitez www.novacyt.com pour en savoir plus Technologies Investisseurs Site Web Diagnostic Moléculaire Novacyt
BRIEF published on 09/17/2024 at 10:27, 1 year 7 months ago Novacyt Announces HY 2024 Results and Investor Webinar Financial Results Investor Presentation Webinar Diagnostics Novacyt
BRIEF published on 09/17/2024 at 10:27, 1 year 7 months ago Novacyt annonce ses résultats du premier semestre 2024 et un webinaire destiné aux investisseurs Résultats Financiers Webinaire Presentation Aux Investisseurs Diagnostic Novacyt
PRESS RELEASE published on 09/17/2024 at 10:26, 1 year 7 months ago Launch of new website Novacyt S.A. announces the launch of its new website which better reflects the expanded Group following the acquisition of Yourgene Health. Visit novacyt.com for more information Intégration Molecular Diagnostics New Website Novacyt S.A. Yourgene Health
PRESS RELEASE published on 09/17/2024 at 10:24, 1 year 7 months ago Information sur les résultats du 1er semestre 2024 et présentation aux investisseurs Novacyt annonce ses résultats du 1er semestre 2024 et une présentation aux investisseurs le 26 septembre 2024. Webinaire interactif avec Lyn Rees et Steve Gibson Résultats Semestriels Webinaire Investisseurs Diagnostic Moléculaire Novacyt
PRESS RELEASE published on 09/17/2024 at 10:22, 1 year 7 months ago Notice of Half Year 2024 Results and Investor Presentation Novacyt S.A. to report half year 2024 results on 26 Sep 2024. Investor webinar scheduled. Novacyt is an international molecular diagnostics company with diverse technologies and services Financial Presentation Half Year Results Molecular Diagnostics Investor Webinar Novacyt S.A.
Published on 05/16/2026 at 01:15, 14 hours 57 minutes ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 16 hours 12 minutes ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 17 hours 2 minutes ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 17 hours 12 minutes ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/16/2026 at 16:08, 4 minutes ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 20 hours 2 minutes ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 22 hours 2 minutes ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 1 day 1 hour ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 1 day 1 hour ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 1 day 6 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 2 days 7 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 2 days 22 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
